Agape ATP (NASDAQ:ATPC) Releases Quarterly Earnings Results

Agape ATP (NASDAQ:ATPCGet Free Report) posted its earnings results on Friday. The company reported ($0.33) earnings per share for the quarter, FiscalAI reports. The business had revenue of $0.27 million during the quarter. Agape ATP had a negative return on equity of 9.91% and a negative net margin of 149.90%.

Agape ATP Stock Performance

Agape ATP stock traded up $0.03 during mid-day trading on Friday, hitting $2.21. 17,628 shares of the company traded hands, compared to its average volume of 53,829. Agape ATP has a one year low of $1.72 and a one year high of $119.00. The stock has a market cap of $2.21 million, a price-to-earnings ratio of -0.15 and a beta of -0.92. The stock has a fifty day moving average price of $2.70 and a 200-day moving average price of $16.89.

Institutional Investors Weigh In On Agape ATP

A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC raised its stake in shares of Agape ATP Corporation (NASDAQ:ATPCFree Report) by 95.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 0.01% of the company’s stock.

Analysts Set New Price Targets

ATPC has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a research note on Wednesday, January 21st. Wall Street Zen upgraded shares of Agape ATP from a “sell” rating to a “hold” rating in a research report on Sunday, April 12th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Agape ATP has an average rating of “Sell”.

Check Out Our Latest Analysis on ATPC

Agape ATP Company Profile

(Get Free Report)

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.

Further Reading

Earnings History for Agape ATP (NASDAQ:ATPC)

Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.